This video is normally available to paying customers.
You may unlock this video for FREE. Enter your email address for instant access AND to receive ongoing updates and special discounts related to this topic.
The **Hepatitis C virus (HCV)** replicates in the liver, leading to inflammation and potentially cirrhosis or liver cancer. There are six main strains of the virus, with genotype 1 and genotype 3 being the most prevalent in the UK.
The disease can incubate for decades within the body, and the exact number of infections is not fully known. It is estimated that approximately 215,000 people are infected with Hepatitis C in the UK. **Most cases occur among individuals who inject illegal drugs**, with up to half of injecting drug users becoming infected.
About 80% of those exposed to HCV develop a chronic infection, while 20% are able to naturally clear the virus through immunity. Symptoms are not a reliable indicator and often resemble those of Hepatitis B (HBV), including:
Hepatitis C is primarily spread through:
Treatment for Hepatitis C can be successful through medication over several weeks. The infection is categorised as:
**Hepatitis C treatment** typically involves:
Regular blood tests monitor treatment efficacy. Side effects vary based on medication type, patient, and concurrent medications. Caution is advised regarding **Hepatitis C medications during pregnancy**, as they can pass to the unborn child, delaying treatment until after birth.
Treatment success depends on the virus strain. Recent advancements have improved cure rates for previously challenging strains like genotype 1. **Unsuccessful treatments** prompt exploration of alternative or combination medications to clear the infection.
It is vital to note that successful virus clearance does not confer immunity, and reinfection remains possible.